BlackRock’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.9M Buy
10,101,715
+1,538,296
+18% +$3.18M ﹤0.01% 2952
2025
Q1
$18.8M Sell
8,563,419
-27,323
-0.3% -$60.1K ﹤0.01% 2948
2024
Q4
$13.1M Buy
8,590,742
+56,175
+0.7% +$85.9K ﹤0.01% 3239
2024
Q3
$17M Buy
8,534,567
+209,182
+3% +$416K ﹤0.01% 3101
2024
Q2
$29.1M Buy
8,325,385
+1,039,357
+14% +$3.64M ﹤0.01% 2713
2024
Q1
$20.2M Buy
7,286,028
+123,676
+2% +$343K ﹤0.01% 2939
2023
Q4
$12.2M Sell
7,162,352
-964,497
-12% -$1.64M ﹤0.01% 3219
2023
Q3
$8.37M Sell
8,126,849
-249,719
-3% -$257K ﹤0.01% 3390
2023
Q2
$9.72M Sell
8,376,568
-1,024,516
-11% -$1.19M ﹤0.01% 3362
2023
Q1
$14.2M Sell
9,401,084
-249,625
-3% -$377K ﹤0.01% 3078
2022
Q4
$24.1M Buy
9,650,709
+392,406
+4% +$981K ﹤0.01% 2873
2022
Q3
$39.1M Buy
9,258,303
+462,403
+5% +$1.95M ﹤0.01% 2606
2022
Q2
$24.5M Buy
8,795,900
+639,769
+8% +$1.78M ﹤0.01% 2919
2022
Q1
$46.7M Buy
8,156,131
+473,930
+6% +$2.71M ﹤0.01% 2594
2021
Q4
$70.1M Buy
7,682,201
+9,333
+0.1% +$85.2K ﹤0.01% 2404
2021
Q3
$82M Buy
7,672,868
+151,019
+2% +$1.61M ﹤0.01% 2313
2021
Q2
$117M Buy
7,521,849
+384,539
+5% +$5.97M ﹤0.01% 2144
2021
Q1
$116M Buy
7,137,310
+250,378
+4% +$4.06M ﹤0.01% 2095
2020
Q4
$146M Buy
6,886,932
+1,060,614
+18% +$22.4M ﹤0.01% 1821
2020
Q3
$86.3M Sell
5,826,318
-491,236
-8% -$7.28M ﹤0.01% 1942
2020
Q2
$92.9M Buy
6,317,554
+667,378
+12% +$9.82M ﹤0.01% 1864
2020
Q1
$66.3M Sell
5,650,176
-118,026
-2% -$1.39M ﹤0.01% 1889
2019
Q4
$136M Buy
5,768,202
+693,516
+14% +$16.3M 0.01% 1763
2019
Q3
$93.9M Buy
5,074,686
+173,294
+4% +$3.21M ﹤0.01% 1931
2019
Q2
$91.1M Buy
4,901,392
+42,657
+0.9% +$793K ﹤0.01% 1965
2019
Q1
$119M Sell
4,858,735
-54,271
-1% -$1.33M 0.01% 1760
2018
Q4
$127M Buy
4,913,006
+132,207
+3% +$3.43M 0.01% 1632
2018
Q3
$151M Buy
4,780,799
+236,068
+5% +$7.47M 0.01% 1668
2018
Q2
$177M Buy
4,544,731
+1,032,010
+29% +$40.1M 0.01% 1552
2018
Q1
$97M Buy
3,512,721
+535,285
+18% +$14.8M ﹤0.01% 1866
2017
Q4
$53.9M Buy
2,977,436
+91,012
+3% +$1.65M ﹤0.01% 2229
2017
Q3
$46.6M Buy
2,886,424
+89,873
+3% +$1.45M ﹤0.01% 2318
2017
Q2
$38.7M Buy
2,796,551
+141,706
+5% +$1.96M ﹤0.01% 2391
2017
Q1
$39.8M Buy
2,654,845
+2,652,008
+93,479% +$39.8M ﹤0.01% 2353
2016
Q4
$37K Sell
2,837
-789
-22% -$10.3K ﹤0.01% 3001
2016
Q3
$62K Sell
3,626
-478
-12% -$8.17K ﹤0.01% 2804
2016
Q2
$74K Buy
4,104
+1,991
+94% +$35.9K ﹤0.01% 2691
2016
Q1
$41K Buy
2,113
+1,348
+176% +$26.2K ﹤0.01% 2417
2015
Q4
$20K Sell
765
-289
-27% -$7.56K ﹤0.01% 2547
2015
Q3
$26K Buy
1,054
+500
+90% +$12.3K ﹤0.01% 2203
2015
Q2
$17K Hold
554
﹤0.01% 2426
2015
Q1
$8K Hold
554
﹤0.01% 2806
2014
Q4
$6K Hold
554
﹤0.01% 2972
2014
Q3
$5K Hold
554
﹤0.01% 3026
2014
Q2
$7K Buy
+554
New +$7K ﹤0.01% 2954